Featured News

man looking through microscope in laboratory

Dr. Chris Kevil’s laboratory at LSUHS has discovered that a clinically approved cyclodextrin-based drug called Sugammadex can act as a hydrogen sulfide donor that restores vasoactive hydrogen. This innovation has already gone through initial in vivo testing with promising results.

Read More about LSU Health Shreveport and CarboHyde collaborate to develop cyclodextrins for restoring sulfide in various disease conditions

Our Latest Publication

First page of the PDF file: InsideResearch_Volume1_2023v1

Read Our Research Publications -

Recent Awards

Follow us @ LSUHSResearch


    Latest News from Research

    Research News